Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for quantitative detection of dna point mutations

A quantitative detection method and detection method technology, applied in the direction of biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of high detection cost, incomplete clamping of PNA-LNA clamped PCR, easy pollution of two-step nested PCR, etc. question

Active Publication Date: 2021-05-11
THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problems of low sensitivity, high detection cost, and difficulty in quantification of commonly used clinical gene mutation detection methods, and also to solve the problems of incomplete clamping of PNA-LNA clamped PCR and easy contamination of two-step nested PCR

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for quantitative detection of dna point mutations
  • A method for quantitative detection of dna point mutations
  • A method for quantitative detection of dna point mutations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] The present invention establishes a highly sensitive point mutation detection method, in order to evaluate the detection of clinical samples by the method. We applied this method to the detection of EGFR L858R mutation sites related to targeted drugs in plasma and tissue samples of non-small cell lung cancer.

[0057]EFGR is a common driver gene in non-small cell lung cancer, and its mutations mainly occur in exons 18 / 19 / 20 / 21. EGFR L858R (NCBI accession number: NG_007726.1) is the 858th amino acid encoded by exon 21 of the EGFR gene, which is changed from leucine to arginine. This mutation can cause the activation of the downstream pathway of EGFR, and then lead to the occurrence of tumors . Iressa (Iressa) and Tarceva (Tarceva) are common EGFR tyrosine kinase inhibitors, and are currently commonly used targeted drugs for the treatment of non-small cell lung cancer. A large number of studies have shown that EGFR L858R is one of the sensitive mutations of Iressa and T...

Embodiment 2

[0066] The method of the present invention is the development and improvement of the PNA-LNA clamped PCR technique, so the method of the present invention and the PNA-LNA clamped PCR technique have been compared with each other. The difference between the two methods in terms of amplification sensitivity and mutation detection sensitivity was mainly compared.

[0067] 1. The primers and sequences of the experimental group and the matched group 1 of the present invention are the same as in Example 1;

[0068] 2. Preparation of standard substances with known content: NCI-H1975 cells containing mutant EGFR L858R and H293T cells containing wild-type EGFR L858R were purchased from American Type Culture Collection (Rockville, USA);

[0069] The EGFR L858R wild-type and mutant DNA in the cells were quantified by digital PCR, and used as standards of known content of the wild-type and mutant DNA, respectively. The EGFR L858R mutant cell DNA of known concentration was diluted to 10 by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The present invention provides a DNA point -to -quantitative quantitative detection method. Through the PNA probe twice to suppress wild -type templates, it has greatly suppressed the amplification of wild templates and solves the problem of incomplete PNA restraint.At the same time, the use of the difference between the tm value of the amplification primers and the temperature control of the annealing temperature during amplification, so that the nest PCR can be performed in a single tube, which enhances the amplification intensity and amplification specificity.The enlarged clinical samples with extremely low copies are possible.Finally, through the real -time fluorescent tube check detection, real -time detection is achieved, but also the cross pollution of the sample is avoided, and the quantitative mutation is also achieved.In addition, this method only requires ordinary real -time fluorescent PCR instruments, and the test results can be obtained within 2H. The cost of reagent is low, which can achieve rapid and low -cost detection of samples.In short, the successful establishment of this method can provide a new method of testing a high -sensitive, high -specific, simple and fast, pollution -free and low -cost detection method for the detection of clinical DNA dots.

Description

technical field [0001] The invention relates to the field of biological technology, in particular to the technical field of biological gene detection. Background technique [0002] Methods commonly used in clinical detection of gene mutations mainly include Sanger sequencing, pyrosequencing, restriction fragment length polymorphism (Restriction Fragment Length Polymorphism, RFLP), etc. These methods have very low sensitivity and can only detect more than 5%~ 20% of mutation samples are difficult to meet the detection requirements of clinical samples. Real-time fluorescent quantitative PCR (Real-time PCR, RT-PCR), amplification retardation mutation system (Amplification Refractory Mutation System, ARMS), high-resolution melting curve (High-resolution Melting, HRM) method, mutation enrichment PCR (Mutant Enrichment Compared with the Sanger sequencing method, the sensitivity of methods such as multiplex PCR amplification method (Coamplification at lower denaturation temperatur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12Q1/6858C12Q1/6848
CPCC12Q1/6848C12Q1/6858C12Q1/6886C12Q2600/156C12Q2600/166C12Q2525/107C12Q2525/113C12Q2537/159C12Q2537/163C12Q2549/119
Inventor 陈之遥缪丽燕赵军张华包健安陈蓉刘筱雪张诗超丁成马晟薛领
Owner THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com